Delirium, Dementia, Amnestic, Cognitive Disorders
Welcome,         Profile    Billing    Logout  
 122 Companies   196 Products   196 Products   116 Mechanisms of Action   3 Trials   2338 News 


«12345678910111213...4647»
  • ||||||||||  Trial completion:  Exercise Effects in Huntington's Disease (clinicaltrials.gov) -  Jun 13, 2018   
    P=N/A,  N=40, Completed, 
    Active, not recruiting --> Completed | N=24 --> 15 | Trial completion date: Oct 2018 --> Nov 2017 | Trial primary completion date: May 2018 --> Nov 2017 Recruiting --> Completed
  • ||||||||||  midazolam hydrochloride / Generic mfg.
    Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date, Surgery:  Decreasing the Incidence of Delirium After Cardiac Surgery (clinicaltrials.gov) -  Jun 12, 2018   
    P4,  N=0, Withdrawn, 
    Recruiting --> Completed N=200 --> 0 | Trial completion date: Dec 2018 --> Aug 2017 | Not yet recruiting --> Withdrawn | Trial primary completion date: Dec 2018 --> Aug 2017
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  ACES: The Aerobic & Cognitive Exercise Study (clinicaltrials.gov) -  May 3, 2018   
    P=N/A,  N=111, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Jun 2016 --> Jul 2017 | Trial primary completion date: Jun 2016 --> Jul 2017
  • ||||||||||  Trial completion date, Trial primary completion date:  18F-AV-1451 High Resolution Autopsy Study (clinicaltrials.gov) -  May 3, 2018   
    P1,  N=10, Active, not recruiting, 
    Active, not recruiting --> Completed | Trial completion date: Jun 2016 --> Jul 2017 | Trial primary completion date: Jun 2016 --> Jul 2017 Trial completion date: Mar 2018 --> Jun 2018 | Trial primary completion date: Mar 2018 --> Jun 2018
  • ||||||||||  Trial completion:  Shanghai Mild Cognitive Impairment Cohort Study (clinicaltrials.gov) -  Apr 25, 2018   
    P=N/A,  N=400, Completed, 
    Recruiting --> Completed | Phase classification: P1 --> PN/A Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy (clinicaltrials.gov) -  Apr 23, 2018   
    P=N/A,  N=280, Completed, 
    Active, not recruiting --> Terminated Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2017 | Trial primary completion date: Sep 2017 --> Dec 2017
  • ||||||||||  Phase classification, Enrollment change:  The Genetic Characterization of Dementia (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=87, Completed, 
    Recruiting --> Completed | Trial completion date: Jun 2016 --> Mar 2018 | Trial primary completion date: Dec 2015 --> Sep 2017 Phase classification: P=N/A --> P | N=300 --> 87
  • ||||||||||  Phase classification, Enrollment change:  Early Markers of Cognitive Change and Alzheimer s Disease (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=2850, Completed, 
    Phase classification: P=N/A --> P | N=300 --> 87 Phase classification: P=N/A --> P | N=5000 --> 2850
  • ||||||||||  Phase classification, Enrollment change:  Living With Frontotemporal Dementia (clinicaltrials.gov) -  Apr 6, 2018   
    P,  N=16, Terminated, 
    Active, not recruiting --> Completed Phase classification: P=N/A --> P | N=40 --> 16
  • ||||||||||  tetrabenazine / Generic mfg.
    Trial completion, Enrollment change:  Effect of Tetrabenazine on Stroop Interference in HD (clinicaltrials.gov) -  Apr 2, 2018   
    P4,  N=2, Completed, 
    Phase classification: P2 --> P=N/A Recruiting --> Completed | N=10 --> 2
  • ||||||||||  Phase classification:  Hereditary Deficits in Auditory Processing Leading to Language Impairment (clinicaltrials.gov) -  Mar 30, 2018   
    P,  N=875, Completed, 
    Trial completion date: Mar 2021 --> Apr 2018 | Trial primary completion date: Feb 2019 --> Apr 2018 Phase classification: P=N/A --> P
  • ||||||||||  davunetide intranasal (AL-108) / Endo
    Trial completion:  Davunetide (AL-108) in Predicted Tauopathies - Pilot Study (clinicaltrials.gov) -  Mar 26, 2018   
    P2,  N=12, Completed, 
    Phase classification: P=N/A --> P | N=40 --> 15 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification, Enrollment change:  The SOMNUS Study: Sedative Optimization Via Monitoring Neurological Status (clinicaltrials.gov) -  Mar 8, 2018   
    P=N/A,  N=28, Completed, 
    Phase classification: P3 --> P=N/A | N=10400 --> 4246 Active, not recruiting --> Completed | Phase classification: P3 --> PN/A | N=200 --> 28
  • ||||||||||  Trial completion date, Trial primary completion date, HEOR:  Behavioral Interventions to Prevent or Delay Dementia (clinicaltrials.gov) -  Feb 28, 2018   
    P=N/A,  N=600, Active, not recruiting, 
    Trial completion date: Feb 2018 --> Apr 2018 Trial primary completion date: Mar 2018 --> Dec 2018 | Trial completion date: Mar 2018 --> Dec 2018
  • ||||||||||  rivastigmine transdermal / Generic mfg.
    Trial completion:  RIVET: Rivastigmine Patch in Veterans With Cognitive Impairment Following TBI (clinicaltrials.gov) -  Feb 27, 2018   
    P3,  N=94, Completed, 
    Trial primary completion date: Mar 2018 --> Dec 2018 | Trial completion date: Mar 2018 --> Dec 2018 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Trial completion date, Trial primary completion date:  Massage Technique for Pain, Anxiety and Delirium in SAH Patients (clinicaltrials.gov) -  Feb 23, 2018   
    P=N/A,  N=50, Completed, 
    Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Mar 2018 --> Feb 2018 | Trial primary completion date: Jan 2018 --> Dec 2017
  • ||||||||||  haloperidol / Generic mfg., quetiapine / Generic mfg.
    Trial completion, Enrollment change, Trial primary completion date:  Haloquet: Trial Comparing Haloperidol, Quetiapine and Placebo in the Pharmacological Treatment of Delirium (clinicaltrials.gov) -  Feb 9, 2018   
    P3,  N=107, Completed, 
    N=30 --> 1 | Trial primary completion date: Apr 2015 --> Dec 2017 Recruiting --> Completed | N=45 --> 107 | Trial primary completion date: Sep 2015 --> Sep 2016
  • ||||||||||  Enrollment change, Trial completion date, Trial termination, Trial primary completion date:  Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment (clinicaltrials.gov) -  Feb 6, 2018   
    P=N/A,  N=97, Terminated, 
    Trial primary completion date: Dec 2012 --> Dec 2016 | Trial completion date: Dec 2012 --> Dec 2017 N=360 --> 97 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Dec 2017 | Trial completion date: Sep 2019 --> Dec 2017; Due to difficulties in patient recruitment
  • ||||||||||  donepezil / Generic mfg.
    Trial completion, Phase classification, Enrollment change, Trial primary completion date:  Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease (clinicaltrials.gov) -  Feb 5, 2018   
    P1,  N=41, Completed, 
    N=360 --> 97 | Recruiting --> Terminated | Trial primary completion date: Sep 2017 --> Dec 2017 | Trial completion date: Sep 2019 --> Dec 2017; Due to difficulties in patient recruitment Recruiting --> Completed | Phase classification: P1/2 --> P1 | N=30 --> 41 | Trial primary completion date: Dec 2012 --> Aug 2012
  • ||||||||||  Enrollment closed, Trial completion date, Trial primary completion date, Surgery:  DeprPOCD: Study of Depressive Symptoms Predicting Postoperative Cognitive Dysfunction (clinicaltrials.gov) -  Feb 5, 2018   
    P=N/A,  N=300, Active, not recruiting, 
    Recruiting --> Completed | Phase classification: P1/2 --> P1 | N=30 --> 41 | Trial primary completion date: Dec 2012 --> Aug 2012 Completed --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Jul 2018 | Trial completion date: Jul 2017 --> Oct 2018
  • ||||||||||  Trial completion, Enrollment change:  Pilot Testing a New Computer-based Screening Tool to Detect Cognitive Impairment (clinicaltrials.gov) -  Jan 31, 2018   
    P=N/A,  N=152, Completed, 
    Completed --> Active, not recruiting | Trial primary completion date: Jul 2017 --> Jul 2018 | Trial completion date: Jul 2017 --> Oct 2018 Not yet recruiting --> Completed | N=300 --> 152
  • ||||||||||  Trial completion, Trial primary completion date:  Tau Imaging of Chronic Traumatic Encephalopathy (clinicaltrials.gov) -  Jan 24, 2018   
    P2,  N=30, Completed, 
    Recruiting --> Completed | N=50 --> 24 Enrolling by invitation --> Completed | Trial primary completion date: Dec 2017 --> Sep 2016
  • ||||||||||  olanzapine / Generic mfg., tetrabenazine / Generic mfg.
    Trial completion, Trial primary completion date:  NEUROHD: Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride (clinicaltrials.gov) -  Jan 19, 2018   
    P3,  N=180, Completed, 
    Enrolling by invitation --> Completed | Trial primary completion date: Dec 2017 --> Sep 2016 Recruiting --> Completed | Trial primary completion date: Mar 2016 --> Apr 2017